Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study)

Patients with transplant‐ineligible relapsed and refractory multiple myeloma (RRMM) have a short life expectancy, especially when they have failed both the proteasome inhibitor and immunomodulator therapies. This study aimed to assess the efficacy and safety of pomalidomide, cyclophosphamide, and de...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Hematol
Hlavní autoři: Lee, Ho Sup, Kim, Kihyun, Kim, Seok Jin, Lee, Je‐Jung, Kim, Inho, Kim, Jin Seok, Eom, Hyeon‐Seok, Yoon, Dok Hyun, Suh, Cheolwon, Shin, Ho‐Jin, Mun, Yeung‐Chul, Kim, Min Kyoung, Lim, Sung‐Nam, Choi, Chul Won, Kang, Hye Jin, Yoon, Sung‐Soo, Min, Chang‐Ki
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Inc. 2020
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7983889/
https://ncbi.nlm.nih.gov/pubmed/31919872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25726
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky